NASDAQ: NKTXNkarta Inc Stock Ownership - Who owns Nkarta?
Insider buying vs selling
Have Nkarta Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul J. Hastings | Chief Executive Officer | 2025-06-18 | 1,790 | $1.79 | $3.20kSell |
| Alicia J. Hager | Chief Legal Officer | 2025-01-15 | 9,584 | $2.20 | $21.08kSell |
| Paul J. Hastings | Chief Executive Officer | 2025-01-15 | 17,378 | $2.20 | $38.23kSell |
| Ralph Brandenberger | Chief Technical Officer | 2025-01-15 | 7,447 | $2.20 | $16.38kSell |
| Alyssa Levin | Chief Financial and Business Officer | 2025-01-15 | 5,838 | $2.20 | $12.84kSell |
| David Shook | Chief Medical Officer Head of Research Development | 2025-01-15 | 8,638 | $2.20 | $19.00kSell |
| David Shook | Chief Medical Officer Head of Research Development | 2024-08-21 | 1,352 | $5.11 | $6.91kSell |
NKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NKTX insiders and whales buy or sell their stock.
NKTX Shareholders
What type of owners hold Nkarta Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 15.23% | 10,805,129 | $19.77M | Institution |
| Tang Capital Management LLC | 9.94% | 7,055,576 | $12.91M | Institution |
| Blackrock Inc | 6.38% | 4,529,416 | $8.29M | Institution |
| Simeon George | 5.64% | 3,999,999 | $7.32M | Insider |
| Samsara Biocapital LLC | 5.31% | 3,768,035 | $6.90M | Institution |
| Nea Management Company LLC | 5.03% | 3,568,781 | $6.53M | Institution |
| Citadel Advisors LLC | 4.94% | 3,508,493 | $6.42M | Institution |
| Sr One Capital Management LP | 4.70% | 3,333,333 | $6.10M | Institution |
| Glaxosmithkline PLC | 4.44% | 3,150,732 | $5.77M | Insider |
| Forest Baskett | 4.09% | 2,902,115 | $5.31M | Insider |
NKTX vs Biotech Stocks
Nkarta Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.